U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543497) titled 'Performance and Impact of the Sepsis ImmunoScore' on Sept. 30, 2025.
Brief Summary: The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Sepsis
Intervention:
DIAGNOSTIC_TEST: Sepsis ImmunoScore
The Sepsis ImmunoScore is a risk stratification tool that uses Artificial Intelligence/Machine Learning to aid in the identification of patients likely to have or progress to sepsis within 24 hours of assessment.
Recruitment Status: NOT_YET_RECRUITING
Spo...